Glucagon Clearance is Preserved in Type 2 Diabetes by Magnus F.G. Grøndahl (11576700)

Peripheral Blood Proteins Distinguish IPF Patients from Controls by Ivan O Rosas (91093)

“…All counts are listed as control/IPF. Concentrations are in ng/ml. In the subgroup with high MMP7 concentration but low MMP1 concentration (14 IPF samples, five control samples), splitting on IGFBP1 and TNFRSF1A improves classification, while in the subgroup with low MMP7, MMP8 improves classification.…”

CD20-TCB induces resident T cell proliferation and recruitment of peripheral blood T cells. by Floriana Cremasco (5580266)

“…<p>a-c) Top: Representative histological staining of WSU DLCL2 tumors 24h post second treatment (0.5 mg/kg CD20-TCB or suitable vehicle i.v.). Bottom: Quantification of total number of cells/mm² from histological images of vehicle <i>vs</i> CD20-TCB treatment. …”

Induced acetylation of the replication fork increases DNA damage. by Benilde García-de Teresa (17838878)

“…<b>(G)</b> For chromosome breakage analysis cells were pre-treated with SAHA [1 μM] for 24h (orange arrow) before inducing chromosomal aberrations with DEB [5 ng/mL] and the culture was continued for additional 48h (dark gray arrow). …”

Endothelial cell activation is attenuated by everolimus via transcriptional and post-transcriptional regulatory mechanisms after drug-eluting coronary stenting by Zsolt Fejes (844136)

“…We studied the effect of everolimus on E-selectin (SELE) and VCAM1 mRNA levels when human coronary artery (HCAECs) and human umbilical vein ECs were challenged with recombinant TNF-α (100 ng/mL) for 1–24 hours in the presence or absence of everolimus using 0.5 μM concentration locally maintained by DES. …”

Supplementary Material for: The Aldosterone/Renin Ratio as a Diagnostic Tool for the Diagnosis of Primary Hypoaldosteronism in Newborns and Infants by Ruecker B. (4152979)

Sirt6 promotes DNA damage repair in osteoarthritis chondrocytes by activating the Keap1/Nrf2/HO-1 signaling pathway by Ling-Wei Mao (18014907)

Effects of TNF-α and atRA on Sox9 activity by Jason S Rockel (18877)

Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities by Baigalmaa Lkhagva (5172662)

Fig. S40. IVG plot of the depth and breadth of genome coverage obtained by the mapping to the 10-CrypGS<i> </i>reference file from double-enriched (D), single-enriched (S), and une... by Natalia J Bayona Vásquez (16388913)

Effect of Chronic Blood Transfusion on Biomarkers of Coagulation Activation and Thrombin Generation in Sickle Cell Patients at Risk for Stroke by Hyacinth I. Hyacinth (305056)

“…At study exit, median hemoglobin level was significantly higher while median TCD velocity was significantly lower in Tx compared to SC subjects. Median vWF (409.6 vs. 542.9 μg/ml), TAT (24.8 vs. 40.0 ng/ml) and D-dimer (9.2 vs. 19.1 μg/ml) levels were also significantly lower in the Tx compared to the SC group at study exit. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”

Effect of Oxidation and Protonation States on [2Fe–2S] Cluster Nitrosylation Giving {Fe(NO)₂}⁹ Dinitrosyl Iron Complexes (DNICs) by Christine E. Schiewer (6112373)

“…This work now compares the nitrosylation of [2Fe–2S] clusters with SN- or NN-chelating benzimidazolate/thiophenolate or bis­(benzimidazolate) capping ligands in their diferric (<b>1</b>^<b>2–</b> and <b>2</b>^<b>2–</b>) and mixed-valent (Fe^IIFe^III, <b>1</b>^<b>3–</b>, and <b>2</b>^<b>3–</b>) forms. …”